000			01984 a2200601 4500
005			20250517094939.0
264		0	_c20180326
008			201803s 0 0 eng d
022			_a2045-2322
024	7		_a10.1038/srep25806 _2doi
040			_aNLM _beng _cNLM
100	1		_aBailly, B
245	0	0	_aTargeting human respiratory syncytial virus transcription anti-termination factor M2-1 to inhibit in vivo viral replication. _h[electronic resource]
260			_bScientific reports _c05 2016
300			_a25806 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAlkaloids _xpharmacology
650	0	4	_aAnimals
650	0	4	_aCell Line
650	0	4	_aDNA-Directed RNA Polymerases _xmetabolism
650	0	4	_aDisease Models, Animal
650	0	4	_aDrug Resistance, Viral _xdrug effects
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Viral _xdrug effects
650	0	4	_aHumans
650	0	4	_aMice, Inbred BALB C
650	0	4	_aModels, Molecular
650	0	4	_aRespiratory Syncytial Virus Infections _xdrug therapy
650	0	4	_aRespiratory Syncytial Virus, Human _xdrug effects
650	0	4	_aSmoothened Receptor _xmetabolism
650	0	4	_aTranscription, Genetic _xdrug effects
650	0	4	_aVeratrum _xchemistry
650	0	4	_aVeratrum Alkaloids _xchemistry
650	0	4	_aViral Proteins _xmetabolism
650	0	4	_aVirus Replication _xdrug effects
700	1		_aRichard, C-A
700	1		_aSharma, G
700	1		_aWang, L
700	1		_aJohansen, L
700	1		_aCao, J
700	1		_aPendharkar, V
700	1		_aSharma, D-C
700	1		_aGalloux, M
700	1		_aWang, Y
700	1		_aCui, R
700	1		_aZou, G
700	1		_aGuillon, P
700	1		_avon Itzstein, M
700	1		_aEléouët, J-F
700	1		_aAltmeyer, R
773	0		_tScientific reports _gvol. 6 _gp. 25806
856	4	0	_uhttps://doi.org/10.1038/srep25806 _zAvailable from publisher's website
999			_c26034002 _d26034002